FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a topical pharmaceutical preparation for treating inflammatory skin pathologies, preferentially an ischemia-related skin pathology. The above preparation contains a supernatant of normal saline prepared by culturing for at least 1 hour peripheral blood mononuclear cells (PBMC) or their subpopulation in normal saline free from substances promoting the PBMC proliferation and activating the PBMC in the stress-inducing environment. Also, the invention refers to a method for producing and using the above preparation.
EFFECT: invention promotes relieving the symptoms of the inflammatory skin pathologies and the healing process.
20 cl, 18 dwg, 5 ex
| Title |
Year |
Author |
Number |
| PHARMACEUTICAL PREPARATION |
2009 |
|
RU2542512C2 |
| ADHESIVE ADIPOCYTE OR PLACENTA CELLS AND USE THEREOF FOR THERAPEUTIC PURPOSES |
2008 |
- Meiron Moran
- Toren Amir
- Ofir Rachel
- Aberman Zami
- Drori-Carmi Nirit
|
RU2709780C2 |
| BIOLOGICALLY ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION IN THE FORM OF STERILE AQUEOUS DISPERSION FOR CONJUNCTIVAL IN THE FORM OF DROPS AND SUBJUNCTIVAL, PARA -, RETROBULBAR INJECTION ADMINISTRATION IN THE CONDUCTED THERAPIES OF VASCULAR AND DYSMETABOLIC OPHTHALMOLOGICAL DISEASES |
2021 |
- Nazarenko Anna Borisovna
- Sokolov Mikhail Anatolevich
|
RU2771678C1 |
| LINEAR OR CYCLIC PEPTIDES, THEIR USING AND METHOD OF PATIENT TREATMENT |
1993 |
- Anders Dzhorgen Andersen
- Rodzher Aston
- Piter Lui Karlen
- Penelop Rid Dub
- Duglas Kevin Makfadden
- Dehvid Dzhejms Fipps
- Debora Ratdzhen
- Fred Vidmer
|
RU2130317C1 |
| SOLUBLE MEDIATOR |
2012 |
- Bandala Sanchez Ester
- Dromi Dzhejms
- Kharrison Leonard Charlz
- Chzhan Yujsya
- Rashidi Maryam
|
RU2660580C2 |
| FATTY ACID ANALOGS FOR TREATING INFLAMMATORY AND AUTOIMMUNE DISORDERS |
2001 |
|
RU2259823C2 |
| MEDICATION, INTENDED FOR TREATMENT AND/OR PREVENTION OF AUTOIMMUNE DISEASE AND FOR FORMATION OF REGULATORY N-CELLS |
2009 |
- Daniela Paul'Zen
- Nina Brunner
- Doroti Brej
|
RU2531936C2 |
| PHARMACEUTICAL COMPOSITION FOR INHIBITION OF INTERLEUKIN-2- -DEPENDENT TUMOR CELLS PROLIFERATION, γ--INTERFERON CONTENT INCREASE, TREATMENT OF PATIENTS WITH INTESTINE INFLAMMATORY DISEASES, INHIBITION POTENTIATION OF CYTOKINE PRODUCTION AND LIMITATION OR INHIBITION OF ALLERGIC RESPONSE OF DELAYED TYPE |
1993 |
- Robert Koffmen
- Jan De Fris
- Rene Dee Vaal' Malefit
- Fiona Pauri
- Dona Rennik
|
RU2120802C1 |
| PROBIOTIC STRAIN OF Bifidobacterium longum, COMPOSITION CONTAINING SUCH STRAIN AND USE THEREOF |
2008 |
- Maksherri Dzhon
- O'Makhouni Lajam
- O'Sallivan Dehvid
- K'Eli Barri
|
RU2473681C2 |
| COMPOSITION FOR TREATING OR PREVENTING ALLERGY OR ALLERGIC REACTION |
2020 |
- Ankersmit, Henrik Jan
- Mildner, Michael
|
RU2827897C1 |
